Oscar Health (NYSE:OSCR - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Wednesday, May 7th. Analysts expect Oscar Health to post earnings of $0.83 per share and revenue of $2.87 billion for the quarter. Oscar Health has set its FY 2025 guidance at EPS.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, analysts expect Oscar Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Oscar Health Price Performance
Shares of OSCR stock traded down $0.29 on Monday, reaching $12.92. The company's stock had a trading volume of 1,326,169 shares, compared to its average volume of 3,913,398. The company has a market capitalization of $3.24 billion, a P/E ratio of -645.18 and a beta of 1.75. Oscar Health has a 12-month low of $11.20 and a 12-month high of $23.79. The stock's 50 day simple moving average is $13.30 and its 200-day simple moving average is $14.64. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.
Institutional Investors Weigh In On Oscar Health
An institutional investor recently raised its position in Oscar Health stock. Thrive Capital Management LLC raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 33.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,343,617 shares of the company's stock after buying an additional 1,588,395 shares during the period. Oscar Health comprises approximately 38.3% of Thrive Capital Management LLC's portfolio, making the stock its 2nd largest position. Thrive Capital Management LLC owned about 2.53% of Oscar Health worth $85,258,000 as of its most recent SEC filing. 75.70% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $20.21.
View Our Latest Stock Analysis on OSCR
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
